This antibody was purified from hybridoma (clone 122) supernatant using protein A agarose. This hybridoma was established by fusion of mouse myeloma cell Sp2/0 with Balb/c mouse splenocyte immunized with the recombinant HVEM.
Target:
HVEM
Application Dilute:
FCM: 10-20 µg/mL (final concentration)
* VAT and and shipping costs not included. Errors and price changes excepted